ENGARDIA

Details for Australian Trade Mark No. 1467153 (hide)

Owner Baxter International Inc.

Convention US 11 February 2011 85/239,827

Service Refer to WIPO Address for Correspondence

Various Convention priority claimed: 10 August 2011, Switzerland, No. 59153/2011 in respect of NONE OF THE GOODS IN THE LIST OF THE INTERNATIONAL APPLICATION COVERED BY THE AMERICAN PRIORITY in class 5.* Convention priority claimed: 11 February 2011, United State

Filing Date 11 August 2011

Classes

Class 5 Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; pharmaceutical products, preparations and substances; sanitary preparations for medical purposes; dietetic substances adapted for medical use; plasters, materials for dressings

Event Publications

19 January 2012 Application Accepted

3 May 2012 Trade Mark Registered/Protected

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the ATMOSS Australian Trade Mark On-line Search System.

Next and Previous Trademarks/Applications

1467154-HEYE

1467152-MINI LABO